Skip to main content
NestleLaunch

Nestle Uses AI to Build a New Food Business Around GLP-1 Drugs

What happened

Nestle has launched Boost Advanced Nutrition Shake in the United States, a product with 35 grams of protein designed to support muscle health during weight loss for consumers of GLP-1 drugs.

Source

Article excerpt

As appetite suppressants reshape eating habits, the food giant is studying muscle loss, hydration and nutrition needs that could define its next growth market. As informed by Reuters Nestle plans to turn the rapid spread of GLP-1 weight-loss drugs from a potential sales risk into a new business area. The company is developing products for people taking medications such as Ozempic and Wegovy, combining nutrition research with artificial intelligence capabilities. The popularity of drugs from Novo Nordisk and Eli Lilly has raised concerns among investors: appetite-suppressing medications could reduce demand for prepared foods, snacks, and beverages for an extended period. At the same time, Nestle sees a separate market in products designed to support people during rapid weight loss and help them manage its effects. Nestle’s head of technology, Stefan Palzer, said the company uses AI to analyze clinical research, identify beneficial nutrient combinations, and create products for GLP-1 consumers. We are well positioned thanks to our portfolio. This is a huge opportunity for our company. – Stefan Palzer The largest manufacturers in the GLP-1 market remain Eli Lilly, with its Mounjaro and Zepbound drugs, and Novo Nordisk, which produces Wegovy and Ozempic. According to Boston Consulting Group estimates, approximately 16 million U.S. residents take these medications, and that...

Keep reading with a free account

The rest of this article, and every signal for Nestle, is in your free account.

Extracted from this sentence

In the United States, Nestle launched Boost Advanced Nutrition Shake, which contains 35 grams of protein and is positioned as a product to support muscles during weight loss.

Extracted by Autobound

From the Signal API record
Event
Launch

What this signalsA launch often needs new go-to-market and support spend.

Product
Boost Advanced Nutrition Shake
Location
United States

The full record

From the Signal API record

Topics and mentions

Product tags

  • medical

Extraction

Confidence
90%
Detected
Aug 17, 2026
signal_type
news
signal_subtype
launches

Use this data

Get every launch signal for Nestle and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Nestle this week?”

  2. Send it to your own tools

    The Signal API returns launch signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/4f4e7d32-ca88-5f77-1a5f-ea90856a107f returns this record as JSON. POST /v1/companies/enrich returns every signal for nestle.com.

{
  "signal_id": "4f4e7d32-ca88-5f77-1a5f-ea90856a107f",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-08-17T07:56:17+00:00",
  "company": {
    "name": "Nestle",
    "domain": "nestle.com"
  },
  "data": {
    "url": "https://mezha.net/eng/bukvy/632633cd_nestle_uses_ai/",
    "title": "Nestle Uses AI to Build a New Food Business Around GLP-1 Drugs - Межа. Новини України.",
    "excerpt": "As appetite suppressants reshape eating habits, the food giant is studying muscle loss, hydration and nutrition needs that could define its next growth market. As informed by Reuters Nestle plans to turn the rapid spread of GLP-1 weight-loss drugs from a potential sales risk into a new business area. The company is developing products for people taking medications such as Ozempic and Wegovy, combining nutrition research with artificial intelligence capabilities. The popularity of drugs from Novo Nordisk and Eli Lilly has raised concerns among investors: appetite-suppressing medications could reduce demand for prepared foods, snacks, and beverages for an extended period. At the same time, Nestle sees a separate market in products designed to support people during rapid weight loss and help them manage its effects. Nestle’s head of technology, Stefan Palzer, said the company uses AI to analyze clinical research, identify beneficial nutrient combinations, and create products for GLP-1 consumers. We are well positioned thanks to our portfolio. This is a huge opportunity for our company. – Stefan Palzer The largest manufacturers in the GLP-1 market remain Eli Lilly, with its Mounjaro and Zepbound drugs, and Novo Nordisk, which produces Wegovy and Ozempic. According to Boston Consulting Group estimates, approximately 16 million U.S. residents take these medications, and that figure...",
    "product": "Boost Advanced Nutrition Shake",
    "summary": "Nestle has launched Boost Advanced Nutrition Shake in the United States, a product with 35 grams of protein designed to support muscle health during weight loss for consumers of GLP-1 drugs.",
    "location": "United States",
    "planning": false,
    "image_url": "https://mezha.net/eng/kd_image_generate/632633cd_nestle_uses_ai/3428969.jpg?ver=2.0.15",
    "confidence": 0.9,
    "product_data": {
      "name": "Boost Advanced Nutrition Shake",
      "full_text": "Boost Advanced Nutrition Shake",
      "fuzzy_match": false
    },
    "product_tags": [
      "medical"
    ],
    "published_at": "2026-08-17T07:56:17Z",
    "location_data": [
      {
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "In the United States, Nestle launched Boost Advanced Nutrition Shake, which contains 35 grams of protein and is positioned as a product to support muscles during weight loss."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.